[{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "786 977 3380", "website": "https://www.pasithea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 76, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 47, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6908, "open": 0.69, "dayLow": 0.681, "dayHigh": 0.69, "regularMarketPreviousClose": 0.6908, "regularMarketOpen": 0.69, "regularMarketDayLow": 0.681, "regularMarketDayHigh": 0.69, "payoutRatio": 0.0, "beta": 0.336, "forwardPE": -0.9708451, "volume": 50410, "regularMarketVolume": 50410, "averageVolume": 4690988, "averageVolume10days": 97420, "averageDailyVolume10Day": 97420, "bid": 0.6802, "ask": 0.7064, "bidSize": 1, "askSize": 1, "marketCap": 5130859, "fiftyTwoWeekLow": 0.673, "fiftyTwoWeekHigh": 7.5, "fiftyDayAverage": 0.9071, "twoHundredDayAverage": 2.178365, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 27774, "profitMargins": 0.0, "floatShares": 6931236, "sharesOutstanding": 7443580, "sharesShort": 190821, "sharesShortPriorMonth": 540028, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0256, "heldPercentInsiders": 0.032679997, "heldPercentInstitutions": 0.13218, "shortRatio": 0.1, "shortPercentOfFloat": 0.026400002, "impliedSharesOutstanding": 7443580, "bookValue": 4.798, "priceToBook": 0.14366403, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -13606982, "trailingEps": -10.6, "forwardEps": -0.71, "lastSplitFactor": "1:20", "lastSplitDate": 1704153600, "enterpriseToEbitda": -0.002, "52WeekChange": -0.88630366, "SandP52WeekChange": 0.1116153, "quoteType": "EQUITY", "currentPrice": 0.6893, "recommendationKey": "none", "totalCash": 5341278, "totalCashPerShare": 0.718, "ebitda": -13240234, "totalDebt": 0, "quickRatio": 3.349, "currentRatio": 3.84, "returnOnAssets": -0.46835998, "returnOnEquity": -0.82812, "freeCashflow": -7945696, "operatingCashflow": -12658110, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KTTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "exchange": "NCM", "messageBoardId": "finmb_702706441", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.217141, "regularMarketPrice": 0.6893, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 4690988, "fiftyTwoWeekLowChange": 0.016300023, "fiftyTwoWeekLowChangePercent": 0.024219945, "fiftyTwoWeekRange": "0.673 - 7.5", "fiftyTwoWeekHighChange": -6.8107, "fiftyTwoWeekHighChangePercent": -0.90809333, "fiftyTwoWeekChangePercent": -88.63036, "earningsTimestamp": 1747339200, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755374400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.6, "epsForward": -0.71, "fiftyDayAverageChange": -0.21780002, "fiftyDayAverageChangePercent": -0.24010585, "twoHundredDayAverageChange": -1.4890649, "twoHundredDayAverageChangePercent": -0.68356997, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1752278338, "regularMarketTime": 1752264001, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "postMarketChangePercent": -1.204121, "postMarketPrice": 0.681, "postMarketChange": -0.008300006, "regularMarketChange": -0.00150001, "regularMarketDayRange": "0.681 - 0.69", "marketState": "CLOSED", "displayName": "Pasithea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]